This activity is designed to engage your critical thinking about patients who may have alpha-1 antityrypsin deficiency (AATD) and to challenge suboptimal approaches to the management of patients with AATD lung disease. You will hear unique insights from 3 clinical experts and a patient living with AATD during this dynamic presentation.
Upon successful completion of this education activity, participants should be better able to:
Director , Alpha-1 Program
Division of Pulmonary, Critical Care, and Sleep Medicine
National Jewish Health
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources